GP-Leds

ICG makes public-to-private CV play in TowerBrook, CD&R de-listing deal

The $1.2bn secondaries transaction involves R1 RCM, a healthcare sector revenue cycle management services provider.

Astorg puts blindpool secondaries fundraising plans on ice

The firm has temporarily delayed capital raising for GP Equity Solutions and is instead focusing on dealmaking, Secondaries Investor has learned.

Kline Hill, Barings partner up again to co-lead single-asset CV for Havis

The deal marks the first continuation vehicle for Guardian Capital Partners.

Commonfund’s Lodge: Not all CVs are working out

While continuation funds are increasingly common liquidity solutions, not all of them are delivering the appropriate returns, according to Cari Lodge, head of secondaries at Commonfund.

Japan’s Ant passes halfway mark in first close on latest fund – updated

The fund will be managed by Ant Solutions Partners, a newly formed spinoff of Ant Capital’s Solution Investment Group.

StepStone backs separate multi-asset deal on back of Gyrus’s single asset

The firm was a participating investor in a single-asset CV for Essential Pharma.

LPs view CVs as a useful exit tool – with a large caveat

Coller Capital’s latest barometer has found that most investors see the main purpose of continuation funds as providing an alternative to selling assets at a low valuation.

Partners Group to build ‘local clusters of scale’ with Bluesea Hotels M&A

The private markets firm backed a GP-led process involving Spain’s Bluesea, a hospitality platform.

$110bn Aussie superfund plans to back more continuation vehicles

The continuation fund market is clearly where the market opportunity is going, according to Aware Super’s deputy chief investment officer and head of international Damien Webb.